Measurement of haloperidol and reduced haloperidol in human plasma using reversed-phase high-performance liquid chromatography.
D002851:Chromatography, High Pressure Liquid; D005260:Female; D006220:Haloperidol / Q000031:analogs & derivatives / Q000097:blood*; D006801:Humans; D007202:Indicators and Reagents; D007700:Kinetics; D010084:Oxidation-Reduction; D013056:Spectrophotometry, Ultraviolet
D007202:Indicators and Reagents; C040693:1-(3-(4-chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine; D006220:Haloperidol